211 related articles for article (PubMed ID: 24253403)
41. Pneumococcal bacteremia in a vaccinated pediatric sickle cell disease population.
Ellison AM; Ota KV; McGowan KL; Smith-Whitley K
Pediatr Infect Dis J; 2012 May; 31(5):534-6. PubMed ID: 22228232
[TBL] [Abstract][Full Text] [Related]
42. Vaccination Timeliness at Age 24 Months in Michigan Children Born 2006-2010.
Wagner AL; Eccleston AM; Potter RC; Swanson RG; Boulton ML
Am J Prev Med; 2018 Jan; 54(1):96-102. PubMed ID: 29254557
[TBL] [Abstract][Full Text] [Related]
43. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--United States, 1998-2003.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2005 Sep; 54(36):893-7. PubMed ID: 16163262
[TBL] [Abstract][Full Text] [Related]
44. Characteristics of long-term care facilities associated with standing order programs to deliver influenza and pneumococcal vaccinations to residents in 13 states.
Shefer A; McKibben L; Bardenheier B; Bratzler D; Roberts H
J Am Med Dir Assoc; 2005; 6(2):97-104. PubMed ID: 15871883
[TBL] [Abstract][Full Text] [Related]
45. Immunization adherence among children with sickle cell disease and sickle cell trait: Results of a population-based study.
Shi JS; Sutaria A; Lakshmanan S; Attell B; Zhou M; Tang A; Eckman J; Snyder A
Pediatr Blood Cancer; 2024 Jul; 71(7):e31042. PubMed ID: 38702922
[TBL] [Abstract][Full Text] [Related]
46. [Fulminating pneumococcal septicemia in a 2 year old child with sickle cell anemia].
Visser M; Hogeman PH; van Vught AJ; Révész T; Wolfs TF
Ned Tijdschr Geneeskd; 2003 Mar; 147(10):454-6. PubMed ID: 12666518
[TBL] [Abstract][Full Text] [Related]
47. Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales.
Melegaro A; Edmunds WJ
Vaccine; 2004 Oct; 22(31-32):4203-14. PubMed ID: 15474710
[TBL] [Abstract][Full Text] [Related]
48. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010.
Naidu L; Chiu C; Habig A; Lowbridge C; Jayasinghe S; Wang H; McIntyre P; Menzies R
Commun Dis Intell Q Rep; 2013 Dec; 37 Suppl():S1-95. PubMed ID: 24410428
[TBL] [Abstract][Full Text] [Related]
49. Effectiveness of the Ten-valent Pneumococcal Conjugate Vaccine Against Tympanostomy Tube Placements in a Cluster-randomized Trial.
Palmu AA; Jokinen J; Nieminen H; Rinta-Kokko H; Ruokokoski E; Puumalainen T; Traskine M; Moreira M; Borys D; Schuerman L; Kilpi TM
Pediatr Infect Dis J; 2015 Nov; 34(11):1230-5. PubMed ID: 26284652
[TBL] [Abstract][Full Text] [Related]
50. Cost effectiveness of pneumococcal vaccination among Dutch infants: economic analysis of the seven valent pneumococcal conjugated vaccine and forecast for the 10 valent and 13 valent vaccines.
Rozenbaum MH; Sanders EA; van Hoek AJ; Jansen AG; van der Ende A; van den Dobbelsteen G; Rodenburg GD; Hak E; Postma MJ
BMJ; 2010 Jun; 340():c2509. PubMed ID: 20519267
[TBL] [Abstract][Full Text] [Related]
51. Invasive pneumococcal disease in Australia, 2004.
Roche PW; Krause VL; Bartlett M; Coleman D; Cook H; Davis C; Fielding JE; Holland R; Giele C; Gilmour R; Kampen R; Brown M; Gilbert L; Hogg G; Murphy D;
Commun Dis Intell Q Rep; 2006; 30(1):80-92. PubMed ID: 16637236
[TBL] [Abstract][Full Text] [Related]
52. Invasive pneumococcal infections among vaccinated children in the United States.
Park SY; Van Beneden CA; Pilishvili T; Martin M; Facklam RR; Whitney CG;
J Pediatr; 2010 Mar; 156(3):478-483.e2. PubMed ID: 19962156
[TBL] [Abstract][Full Text] [Related]
53. Pneumococcal vaccination: effective in children under the age of 2 years.
Prescrire Int; 2009 Dec; 18(104):266. PubMed ID: 20027709
[TBL] [Abstract][Full Text] [Related]
54. Prophylaxis of pneumococcal infection in sickle-cell disease by the combined use of vaccination and penicillin.
Babiker MA
Ann Trop Paediatr; 1986 Sep; 6(3):179-81. PubMed ID: 2430506
[TBL] [Abstract][Full Text] [Related]
55. An emergency department-based vaccination program: overcoming the barriers for adults at high risk for vaccine-preventable diseases.
Rimple D; Weiss SJ; Brett M; Ernst AA
Acad Emerg Med; 2006 Sep; 13(9):922-30. PubMed ID: 16902048
[TBL] [Abstract][Full Text] [Related]
56. Vaccination, underlying comorbidities, and risk of invasive pneumococcal disease.
Yildirim I; Shea KM; Little BA; Silverio AL; Pelton SI;
Pediatrics; 2015 Mar; 135(3):495-503. PubMed ID: 25647674
[TBL] [Abstract][Full Text] [Related]
57. Factors predictive of increased influenza and pneumococcal vaccination coverage in long-term care facilities: the CMS-CDC standing orders program Project.
Bardenheier BH; Shefer A; McKibben L; Roberts H; Rhew D; Bratzler D
J Am Med Dir Assoc; 2005; 6(5):291-9. PubMed ID: 16165069
[TBL] [Abstract][Full Text] [Related]
58. Polyvalent pneumococcal-polysaccharide immunization of patients with sickle-cell anemia and patients with splenectomy.
Ammann AJ; Addiego J; Wara DW; Lubin B; Smith WB; Mentzer WC
N Engl J Med; 1977 Oct; 297(17):897-900. PubMed ID: 20575
[TBL] [Abstract][Full Text] [Related]
59. [Serious invasive pneumococcal disease in young children: the importance of vaccination].
Haveman LM; Geelen SP; Sanders EA; Wolfs TF
Ned Tijdschr Geneeskd; 2002 Oct; 146(41):1917-20. PubMed ID: 12404904
[TBL] [Abstract][Full Text] [Related]
60. [Acceptance of the new conjugate vaccines. Meningococcal and pneumococcal vaccines, in the cohort born in 1999, in the North Region of Portugal].
De Queirós L; Castro L; Ferreira MC; Gonçalves G
Acta Med Port; 2004; 17(1):49-53. PubMed ID: 15636727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
